Skip to main navigation menu Skip to main content Skip to site footer
×
Español (España) | English
Editorial
Home
Indexing
Review

Hematological alterations associated with antiretroviral therapy in patients with human immunodeficiency virus

By
Carla María Taimal Sárez ,
Carla María Taimal Sárez

Universidad Católica de Cuenca, Carrera de Medicina-Campus Cuenca, Cuenca, Ecuador

Search this author on:

PubMed | Google Scholar
Esteban Adrián Reiban Espinoza ,
Esteban Adrián Reiban Espinoza

Universidad Católica de Cuenca, Carrera de Medicina-Campus Cuenca, Cuenca, Ecuador

Search this author on:

PubMed | Google Scholar
Giselle Marina Flores Siranaula ,
Giselle Marina Flores Siranaula

Universidad Católica de Cuenca, Carrera de Medicina-Campus Cuenca, Cuenca, Ecuador

Search this author on:

PubMed | Google Scholar
Paul Alexis Chuquitarco Marín ,
Paul Alexis Chuquitarco Marín

Universidad Católica de Cuenca, Carrera de Medicina-Campus Cuenca, Cuenca, Ecuador

Search this author on:

PubMed | Google Scholar

Abstract

Introduction: Hematological alterations are very frequent and of multifactorial origin, they have been related to an increased risk of pathology progression and morbimortality in patients infected by the human immunodeficiency virus. Although there is a wide variety of scientific studies on the prevalence and pathogenesis of these alterations in HIV-positive patients, there are few investigations in our environment that report on the positive or negative effect of the administration of antiretroviral drugs.
Objective: To determine the main hematologic alterations associated with antiretroviral therapy in patients infected by the human immunodeficiency virus.
Methodology: Narrative bibliographic review. The following databases were used for the research: PubMed, Cochrane and Scopus.
Results: The prevalence of at least one hematological alteration was 1.1-58.6% among HIV-infected patients receiving ART. The most frequent cytopenia was anemia followed by leukopenia and thrombocytopenia. Among the most significant risk factors, patients older than 50 years, female sex, zidovudine-based antiretroviral regimen, low BMI and CD4 T-cell count, high viral load, advanced stage and opportunistic infections were identified.
Conclusions: The toxicity of antiretroviral drugs and the clinical conditions of the HIV-positive patient result in altered hematopoiesis affecting all three cell lines, patients may present with anemia, leukopenia, thrombocytopenia and/or pancytopenia. Failure to monitor and identify these disorders has a serious impact on the natural history of the disease in the patient.

How to Cite

1.
Taimal Sárez CM, Reiban Espinoza EA, Flores Siranaula GM, Chuquitarco Marín PA. Hematological alterations associated with antiretroviral therapy in patients with human immunodeficiency virus. Salud, Ciencia y Tecnología [Internet]. 2022 Dec. 31 [cited 2024 Jul. 4];2:208. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/208

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.